While it's easy to blame Instagram for teen girls' anxiety and low self-satisfaction, we're forgetting that these issues existed prior to social media. Here's what really needs to change. bit.ly/3qYsyy6

Are you pushing away anxiety and other distressing emotions at the cost of your health? Here's how to tell, writes Evan Parks bit.ly/3xALl3A

Holiday Gift Guides for the Psychedelic Lover Surprisingly good article by Forbes forbes.com/sites/amandasi…

Buying as much $LVT as I can at these prices.

This week in Toronto, the Toronto Board of Health voted to ask the federal government to decriminalize small amounts of illegal drug possession Read more 🔽 Globalnews.ca globalnews.ca/news/8429483/t…

News: atai Life Sciences | $ATAI Has been given Investigational New Drug clearance by the FDA to conduct a clinical study of R-ketamine as a potential treatment for treatment-resistant depression. psychedelicfinance.com/articles/atai-…

As we are set to enter a new trading week, let's take a look at the largest positions in the AdvisorShares' #Psychedelics ETF, $PSIL. No surprise, the top three are: Cybin Corp | $CYBN | $1.05 Compass Pathways | $CMPS | $17.90 MindMed | $MNMD | $1.12 @CybinInc mindmedco

As inflation talks continue to rise, what is your investing strategy? The top 5 defense strategies to consider according to Forbes - Increasing Small Cap exposure has historically benefited when looking at inflation adjusted gains forbes.com/sites/leonlabr… #inflation

Companies Advancing MDMA: @NuminusWellness is advancing their single-arm, open-label, first of its kind trial for MDMA-assisted therapy as a potential treatment for PTSD. Their compassionate access trial is in collaboration with MAPS.

Cybin was honored to participate in the 2022 Biotech Showcase and join industry peers on a thoughtful psychedelic panel discussion. Watch the replay here: ir.cybin.com/investors/even…

Breaking: Field Trip withdraws US patent following emergence of relevant Mindset Pharma applications. $FTRP $MSET

Join the $BTTR team on March 24 at 8:30 a.m. ET for our Q4 #earnings call, featuring CEO, Scott Lerner, CFO Sharla Cook, EVP of Sales, Donald Young, and EVP of Strategy, Rob Sauermann. Register now at ow.ly/my1n50ImEKm #chooseBTTR #HaloElevate #stocks #investment #finance

EXPAND ACCESS TO PSYCHEDELIC THERAPY!

PsyBio's presentation will be available to view on demand beginning at 9:00 a.m. ET on Monday, March 28th. Register link 👇

Missed this morning's Q4 Earnings Call? Not a problem! You can rewatch and download our latest presentation here ➡️ (ow.ly/HLgQ50Iv0xF) 🚨⬅️ #ChooseBTTR #HaloPets #HaloElevate #AnnualReport #Q4 #ElevatedPets #stock #stocks #investment #finance #expansion #nyse #stockmarket

Marc Andreessen 🇺🇸 I’ve talked to many more people who were helped by psychedelics & ketamine than SSRIs & amphetamines